Greater China
Hong Kong regulation: Carry on
The proposal to place a 0% tax on carried interest has been welcomed in Hong Kong, but PE industry participants are quietly looking to Hong Kong Monetary Authority to ensure balanced execution of the policy
Fund focus: Oceanpine opens to external capital
Technology and healthcare-focused Oceanpine Capital sees the large GP commitment to its fund and the network of its founder as key differentiators in a competitive Chinese market
CPE, SDIC lead $46m round for China's Jaka Robotics
Chinese industrial robot manufacturer Jaka Robotics has raised RMB300m ($46m) in Series C funding led by CPE and State Development and Investment Corporation (SDIC).
Ascendent founder sponsors SPAC targeting global deals
A special purpose acquisition company (SPAC) sponsored by Liang Meng, founding managing partner of China’s Ascendent Capital Partners, has raised $300 million for global consumer technology investments.
China’s WeRide raises $310m
Chinese autonomous driving start-up WeRide has raised $310 million in Series B funding across three tranches led by Chinese electric bus manufacturer Yutong Group.
Portfolio: MSPEA and Korres
Morgan Stanley Private Equity Asia helped ethical Greek cosmetics maker Korres beef up an underweight international presence with a plan that will see China become the main growth engine
Buyouts in 2021: Winners and losers
Asia could prove to be a deal-rich market in 2021, but buyout investors are still figuring out the long-term implications of COVID-19 for companies that cater to changing consumer demands
China’s CICC raises $650m for biomedical fund
CICC Capital has reached a second close of RMB4.2 billion ($650 million) on its latest healthcare fund - the first in China to receive fast-track approval for its role in addressing COVID-19.
Hong Kong's ORI hits first close on Fund II, exits Kymab
Hong Kong healthcare-focused VC firm ORI Capital has reached a first close of $112 million on its second fund and exited its largest investment, UK biotech developer Kymab, as part of a $1.1 billion deal.
Cathay closes second innovation fund $789m
Cathay Capital has raised EUR650 million ($789 million) for its second innovation fund, which supports start-ups in China, Europe, and North America.
China HR software start-up raises $190m
WorkTrans, a Chinese human resources services provider, has raised $190 million through two tranches, a Series C of $50 million and a Series D of $140 million.
Chinese fitness app Keep raises $360m
Keep, a Chinese mobile app that provides fitness training programs, has raised $360 million in Series F funding led by SoftBank Vision Fund.
China's Firstred closes debut renminbi fund on $1b
Firstred Capital, a Chinese growth and buyout investor in healthcare, consumer products and services, and industrial technology, has closed its debut fund with RMB6.8 billion ($1 billion) in commitments.
Sequoia leads $150m Series B for China's Visen Pharma
China’s Visen Pharmaceuticals, a drug developer targeting glandular conditions such as dwarfism and growth deficiency has raised a $150 million Series B round led by Sequoia Capital China.
China smart storage player Hive Box raises $400m
Hive Box, a China-based self-service package drop-off and pick-up operator, has received $400 million in funding from Trustbridge Partners, Asia Forge, Sequoia Capital China, Redview Capital, and All-Stars Investment. The pre-money valuation is $3 billion.
Goldman leads $50m round for China’s Perfect
Perfect Corp, a Chinese developer of online beauty apps, has raised a $50 million Series C round led by Goldman Sachs.
China's Horizon Robotics raises $400m
Horizon Robotics, a Chinese developer of microprocessors that support artificial intelligence (AI) technologies, has raised $400 million in the second tranche of a Series C round led by Baillie Gifford, Yunfeng Capital, CPE, and electric vehicle battery...
Carlyle leads $123m Series D for China's Abbisko
The Carlyle Group - investing through its Asia growth fund - has led a $123 million Series D round for Chinese cancer-focused biotech developer Abbisko Therapeutics.
China's Primavera launches consumer-focused SPAC
Primavera Capital Group has joined the trickle of Asia-based private equity investors launching special purpose acquisition companies (SPACs) in the US, targeting a $300 million capital raise for consumer deals.
Hillhouse leads $28m round for China's DataCloak
DataCloak, a Shenzhen-based start-up that helps companies install data security systems on devices used by employees, has raised a $28 million Series B round led by Hillhouse Capital.
Hidden Hill leads $110m round for China's Baibu
Chinese B2B fabrics trading platform Baibu has raised $110 million in an extended Series D round led by Hidden Hill Capital, the private equity platform of logistics giant GLP China.
Hong Kong proposes 0% carried interest tax rate
The Hong Kong government has moved to placate private equity industry fears regarding the tax treatment of carried interest by proposing a 0% levy.
Goldman, Anchor commit $100m to China car park operator
Goldman Sachs and Anchor Equity Partners have led a $100 million Series B round for Sunsea Parking, a China-based car parking management company.
China AI chip player Enflame raises $279m Series C
Enflame Technology, a Chinese artificial intelligence (AI) chip designer, has raised a RMB1.8 billion ($279 million) Series C round led by CPE, China Capital Investment Group, and Primavera Capital.
